- Home
- INNV vs CSTL Comparison
INNV vs CSTL Comparison
Compare INNV & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INNV
- CSTL
- Stock Information
- Founded
- INNV 2007
- CSTL 2007
- Country
- INNV United States
- CSTL United States
- Employees
- INNV N/A
- CSTL N/A
- Industry
- INNV Medical/Nursing Services
- CSTL Medical Specialities
- Sector
- INNV Health Care
- CSTL Health Care
- Exchange
- INNV Nasdaq
- CSTL Nasdaq
- Market Cap
- INNV 527.9M
- CSTL 456.2M
- IPO Year
- INNV 2021
- CSTL 2019
- Fundamental
- Price
- INNV $3.89
- CSTL $18.52
- Analyst Decision
- INNV Sell
- CSTL Strong Buy
- Analyst Count
- INNV 2
- CSTL 6
- Target Price
- INNV $5.00
- CSTL $37.67
- AVG Volume (30 Days)
- INNV 32.0K
- CSTL 419.5K
- Earning Date
- INNV 05-06-2025
- CSTL 08-04-2025
- Dividend Yield
- INNV N/A
- CSTL N/A
- EPS Growth
- INNV N/A
- CSTL N/A
- EPS
- INNV N/A
- CSTL N/A
- Revenue
- INNV $831,683,000.00
- CSTL $347,083,000.00
- Revenue This Year
- INNV $13.77
- CSTL N/A
- Revenue Next Year
- INNV $10.12
- CSTL $1.36
- P/E Ratio
- INNV N/A
- CSTL N/A
- Revenue Growth
- INNV 12.19
- CSTL 38.43
- 52 Week Low
- INNV $2.60
- CSTL $15.45
- 52 Week High
- INNV $6.69
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- INNV 54.58
- CSTL 56.09
- Support Level
- INNV $3.62
- CSTL $17.89
- Resistance Level
- INNV $4.03
- CSTL $19.38
- Average True Range (ATR)
- INNV 0.19
- CSTL 0.82
- MACD
- INNV -0.04
- CSTL 0.26
- Stochastic Oscillator
- INNV 57.38
- CSTL 77.46
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.